Tsc22d3tm1.1Efmd
Targeted Allele Detail
|
|
| Symbol: |
Tsc22d3tm1.1Efmd |
| Name: |
TSC22 domain family, member 3; targeted mutation 1.1, Eric F Morand |
| MGI ID: |
MGI:5515629 |
| Synonyms: |
Gilzflox |
| Gene: |
Tsc22d3 Location: ChrX:139440277-139501257 bp, - strand Genetic Position: ChrX, 61.35 cM, cytoband F1
|
| Alliance: |
Tsc22d3tm1.1Efmd page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:201728
|
| Parent Cell Line: |
Bruce 4 (ES Cell)
|
| Strain of Origin: |
B6.Cg-Thy1a
|
|
| Allele Type: |
|
Targeted (Conditional ready, No functional change) |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: A loxP site was inserted usptream of the fourth coding exon. An FRT-flanked neomycin resistance cassette with a 3' loxP site was inserted downstream of the same exon. Flp-mediated recombination removed the neomycin resistance cassette and left the exon floxed.
(J:201728)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Tsc22d3 Mutation: |
3 strains or lines available
|
|
| Original: |
J:201728 Ngo D, et al., Divergent effects of endogenous and exogenous glucocorticoid-induced leucine zipper in animal models of inflammation and arthritis. Arthritis Rheum. 2013 May;65(5):1203-12 |
| All: |
6 reference(s) |
|